Exane Derivatives’s Cognizant CTSH Stock Holding History

Exane Derivatives’s Portfolio CTSH Stock Details CTSH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$742	Sell	11 -90	-89%	-$6.89K	﹤0.01%	535
2022 Q1	$9.06K	Hold	101	–	–	﹤0.01%	681
2021 Q4	$8.96K	Sell	101 -908	-90%	-$73K	﹤0.01%	598
2021 Q3	$74.9K	Buy	1,009 +965	+2,193%	+$71.2K	0.02%	574
2021 Q2	$3.02K	Hold	44	–	–	﹤0.01%	798
2021 Q1	$3.44K	Hold	44	–	–	﹤0.01%	641
2020 Q4	$3.61K	Sell	44 -55	-56%	-$4.19K	﹤0.01%	579
2020 Q3	$6.87K	Hold	99	–	–	﹤0.01%	485
2020 Q2	$5.63K	Sell	99 -1	-1%	-$54	﹤0.01%	443
2020 Q1	$4.65K	Hold	100	–	–	﹤0.01%	456
2019 Q4	$6.18K	Sell	100 -12,384	-99%	-$765K	﹤0.01%	426
2019 Q3	$752K	Sell	12,484 -5,239	-30%	-$331K	0.13%	121
2019 Q2	$1.12M	Sell	17,723 -11,525	-39%	-$756K	0.2%	100
2019 Q1	$2.12M	Buy	29,248 +29,070	+16,331%	+$2.03M	0.42%	71
2018 Q4	$11.3K	Hold	178	–	–	﹤0.01%	455
2018 Q3	$13.7K	Buy	178 +4	+2%	+$313	﹤0.01%	431
2018 Q2	$13.8K	Sell	174 -14,877	-99%	-$1.17M	﹤0.01%	445
2018 Q1	$1.2M	Buy	15,051 +14,742	+4,771%	+$1.17M	0.24%	109
2017 Q4	$21.9K	Sell	309 -227	-42%	-$16.6K	﹤0.01%	382
2017 Q3	$38.9K	Sell	536 -93	-15%	-$6.53K	0.01%	326
2017 Q2	$41.7K	Buy	629 +260	+70%	+$16.5K	0.01%	327
2017 Q1	$22K	Sell	369 -1,398	-79%	-$80.4K	0.01%	323
2016 Q4	$99K	Hold	1,767	–	–	0.02%	251
2016 Q3	$84.3K	Sell	1,767 -511	-22%	-$29.1K	0.01%	256
2016 Q2	$130K	Buy	2,278 +416	+22%	+$25.1K	0.02%	225
2016 Q1	$117K	Buy	1,862 +419	+29%	+$24.4K	0.02%	229
2015 Q4	$86.6K	Buy	1,443 +651	+82%	+$42K	0.01%	224
2015 Q3	$49.6K	Buy	+792	New	+$49.7K	0.01%	265

Other funds holding CTSH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Exane Derivatives's CTSH Position: Q2 2022 in Review

Exane Derivatives reduced its Cognizant (CTSH) stake by 89% in Q2 2022, selling an estimated $6.89K and leaving 11 shares worth $742. The position accounts for ﹤0.01% of the portfolio, ranked #535.

Exane Derivatives first reported a position in CTSH in Q3 2015 and has held it in 28 quarters since. The position peaked at $2.12M in Q1 2019. 917 funds tracked by Wall St. Rank hold CTSH as of Q2 2022.

Exane Derivatives held 11 shares of Cognizant worth $742 as of Q2 2022.
Exane Derivatives sold 90 Cognizant shares in Q2 2022, an estimated $6.89K.
Cognizant made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #535 holding.
Exane Derivatives first reported a position in Cognizant in Q3 2015 and has held it in 28 quarters since.
Exane Derivatives's Cognizant position peaked at $2.12M in Q1 2019.
917 funds tracked by Wall St. Rank held Cognizant as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.